Skip to main content

Advertisement

SpringerLink
Log in

Cytarabine toxicity of the corneal endothelium

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Hollander DA, Aldave AJ (2004) Drug-induced corneal complications. Curr Opin Ophthalmol 15(6):541–548

    Article  PubMed  Google Scholar 

  2. Guthoff T, Tietze B, Meinhardt B et al (2010) Cytosine-arabinoside-induced keratopathy: a model of corneal proliferation kinetics. Ophthalmologica 224(5):308–311

    Article  PubMed  CAS  Google Scholar 

  3. Hopen G, Mondino BJ, Johnson BL, Chervenick PA (1981) Corneal toxicity with systemic cytarabine. Am J Ophthalmol 91(4):500–504

    PubMed  CAS  Google Scholar 

  4. Ritch PS, Hansen RM, Heuer DK (1983) Ocular toxicity from high-dose cytosine arabinoside. Cancer 51(3):430–432

    Article  PubMed  CAS  Google Scholar 

  5. Planer D, Cukierman T, Liebster D et al (2004) Anterior uveitis as a complication of treatment with high-dose cytosine arabinoside. Am J Hematol 76(3):304–306

    Article  PubMed  Google Scholar 

  6. Moberg J, Carlsson M, Holm C, Koranyi G (2009) Severe anterior uveitis as a complication of cytosine arabinoside. Acta Ophthalmol 87(8):922–923

    Article  PubMed  Google Scholar 

  7. Lass JH, Lazarus HM, Reed MD, Herzig RH (1982) Topical corticosteroid therapy for corneal toxicity from systemically administered cytarabine. Am J Ophthalmol 94(5):617–621

    PubMed  CAS  Google Scholar 

  8. Lochhead J, Salmon JF, Bron AJ (2003) Cytarabine-induced corneal toxicity. Eye 17(5):677–678

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We acknowledge Mr. Allan Connor for slit-lamp photography and preparation of the illustrations in this report.

Conflict of interest

Conflict of interest does not exist for any of the authors.

Author information

Authors and Affiliations

  1. Department of Ocular Oncology, Princess Margaret Hospital/UHN, University of Toronto, Toronto, ON, Canada

    Hatem Krema, Ronaldo A. Santiago & Charles J. Pavlin

  2. Department of Medical Oncology, Princess Margaret Hospital/UHN, University of Toronto, Toronto, ON, Canada

    Andre Schuh

  3. Ocular Oncology Service 18-739, Princess Margaret Hospital, 610 University Avenue, Toronto, ON, M5G 2M9, Canada

    Hatem Krema

Authors
  1. Hatem Krema
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ronaldo A. Santiago
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Andre Schuh
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Charles J. Pavlin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hatem Krema.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Krema, H., Santiago, R.A., Schuh, A. et al. Cytarabine toxicity of the corneal endothelium. Ann Hematol 92, 559–560 (2013). https://doi.org/10.1007/s00277-012-1593-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-012-1593-0

Keywords

Search

Navigation